ARCHIVES

Dendreon’s Provenge Approved For Prostate Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Treatment Progress Since 1972 Provides Powerful Support For Continuing National Cancer Program

March 23, 1979

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

Radium Society To Meet In L.A.

March 2, 1979

In Brief: DCPC Still Looking For Yates’ Replacement New jersey Commission Offers New Fellowships

December 4, 1987

Course On Human Research Protections Goes Online @ Cancer.Gov.

January 26, 2001